According to Gram Research analysis, a 2026 study found that removing a brain protein called PTP1B suppressed how rewarding high-fat foods feel to mice, causing them to eat less without affecting their metabolism or weight. Mice without this protein showed no preference for fatty foods and ate significantly less during binge-eating tests, while normal mice craved these foods. This discovery suggests that blocking PTP1B could reduce food cravings in humans, though human studies are needed to confirm the effect.
Scientists discovered that a protein called PTP1B plays a key role in making high-fat foods feel rewarding to your brain. When researchers removed this protein from specific brain regions in mice, the animals lost interest in eating fatty foods—even though they could still eat normally and their metabolism stayed healthy. This finding suggests that targeting this single protein might help people reduce cravings for unhealthy foods without affecting how their body processes energy or sugar. The research could lead to new treatments for overeating and weight management.
Key Statistics
A 2026 research article in Brain Research Bulletin found that mice lacking the PTP1B protein in reward-processing brain regions showed no preference for high-fat foods, while normal mice strongly preferred areas associated with fatty food.
According to the 2026 study, female mice without PTP1B in their dopamine neurons exhibited significantly reduced binge-eating behavior when given unlimited access to high-fat diet, while maintaining normal body weight and blood sugar control.
Gram Research analysis of this 2026 research shows that PTP1B removal in the striatum (reward processing region) suppressed high-fat diet preference without altering glucose tolerance or insulin sensitivity in mice.
The Quick Take
- What they studied: Whether a brain protein called PTP1B controls how rewarding high-fat foods feel to eat
- Who participated: Laboratory mice with and without the PTP1B protein removed from specific brain regions involved in reward and motivation
- Key finding: Mice without PTP1B in their reward brain regions showed no preference for high-fat foods and ate less when given unlimited access, while normal mice craved these foods
- What it means for you: This research suggests that blocking PTP1B could reduce food cravings without affecting normal eating or metabolism, potentially offering a new approach to weight management—though human studies are needed to confirm these effects
The Research Details
Researchers used advanced genetic techniques to create two types of mice missing the PTP1B protein in different brain regions: one group had it removed from dopamine-producing neurons (brain cells that create the ‘reward’ chemical), and another group had it removed from neurons in the striatum (a brain region that processes rewards). They then tested how much these mice liked high-fat foods using a preference test where mice could choose to spend time in areas associated with fatty food. They also measured how much the mice ate when given unlimited access to high-fat food, and checked their weight, blood sugar control, and insulin sensitivity.
The researchers chose this approach because previous studies showed that insulin and leptin (hormones that signal fullness) normally reduce the appeal of fatty foods by working through dopamine neurons. PTP1B is a protein that blocks these hormone signals, so removing it should strengthen the anti-reward effect. By removing PTP1B only from specific brain regions rather than the whole body, the scientists could see exactly where this protein matters for food cravings.
This research design is important because it identifies a specific protein in specific brain locations that controls food cravings. Rather than just showing that something affects eating behavior, it pinpoints the exact mechanism—how PTP1B blocks reward signals—which could lead to targeted treatments. Testing in mice first allows researchers to understand the basic biology before attempting human studies.
This is a controlled laboratory study with genetically modified animals, which allows for precise cause-and-effect conclusions. The researchers tested multiple aspects of metabolism and behavior to ensure the effects were specific to food reward, not general health problems. However, mouse studies don’t always translate directly to humans, and the sample size wasn’t specified in the abstract, which limits our ability to assess statistical reliability.
What the Results Show
The main finding was striking: normal mice strongly preferred spending time in areas where they had eaten high-fat food, showing that they found it rewarding. In contrast, mice without PTP1B in their dopamine neurons or striatum showed no such preference—the high-fat food didn’t seem rewarding to them at all.
When given unlimited access to high-fat food, female mice without PTP1B ate significantly less than normal mice and showed reduced binge-eating behavior. This suggests the protein removal made the food less appealing, so the mice naturally ate less without being forced to restrict themselves.
Importantly, removing PTP1B didn’t break the mice’s normal eating or metabolism. Their body weight stayed similar to normal mice, their blood sugar control remained normal, and their insulin sensitivity (how well their bodies respond to insulin) didn’t change. This is crucial because it shows the effect was specific to food reward, not a general disruption of how the body processes energy.
The research showed that the effect was particularly strong in female mice, suggesting that sex hormones might influence how PTP1B affects food reward. The findings applied to both brain regions tested (dopamine neurons and striatum), indicating that PTP1B controls reward signals in multiple connected brain areas rather than just one location.
This research builds on earlier findings showing that insulin and leptin reduce food cravings through dopamine neurons. By identifying PTP1B as the specific brake on these signals, this study explains a missing piece of how the brain controls eating behavior. Previous research suggested these hormone pathways were important; this work shows exactly which protein blocks them and where.
The study was conducted only in mice, so results may not directly apply to humans. The abstract doesn’t specify how many mice were tested, making it difficult to assess whether the findings are statistically robust. The research focused on high-fat diet specifically, so it’s unclear whether PTP1B affects cravings for other types of unhealthy foods. Additionally, the study measured short-term behavior changes; long-term effects remain unknown. Finally, this is basic research showing what’s possible in theory—developing a safe treatment for humans would require many additional steps.
The Bottom Line
Based on this research, there is moderate evidence that targeting PTP1B could reduce cravings for high-fat foods. However, this is early-stage research in animals, so no dietary or supplement recommendations can be made yet. Anyone interested in managing food cravings should focus on proven strategies: eating regular meals, managing stress, getting adequate sleep, and consulting a healthcare provider about persistent overeating.
This research is most relevant to people struggling with cravings for fatty foods and those interested in obesity treatment development. Researchers and pharmaceutical companies developing new weight-management drugs should pay close attention. People with diabetes or metabolic disorders may find this particularly relevant since the research involved insulin signaling. However, until human studies are completed, this remains basic science rather than actionable medical advice.
If this research leads to a human treatment, it would likely take 5-10 years of additional development, testing, and regulatory approval before becoming available. Even then, benefits would likely appear gradually over weeks to months as the brain’s reward system adjusted, not immediately.
Frequently Asked Questions
What is PTP1B and why does it matter for food cravings?
PTP1B is a brain protein that blocks reward signals from fullness hormones like insulin and leptin. When this protein is removed, the brain’s anti-reward signals work better, making high-fat foods less appealing. This could eventually help people reduce cravings for unhealthy foods.
Can I reduce my food cravings by targeting PTP1B right now?
Not yet—this is early research in mice. No human treatments targeting PTP1B currently exist. Proven strategies for reducing cravings include eating regular meals, managing stress, sleeping well, and consulting a healthcare provider about persistent overeating.
Does blocking PTP1B affect how your body processes food and energy?
In this mouse study, no. Mice without PTP1B maintained normal body weight, blood sugar control, and insulin sensitivity. The protein removal specifically reduced food reward without disrupting normal metabolism, suggesting a targeted approach to reducing cravings.
When will treatments based on this research be available for humans?
If this research leads to human treatments, development typically takes 5-10 years including additional animal studies, human trials, and regulatory approval. Benefits would likely appear gradually over weeks to months as the brain adjusts, not immediately.
Why did the study use mice instead of testing humans directly?
Mouse studies allow researchers to precisely control genetics and measure brain changes that would be difficult in humans. Mice have similar brain reward systems to humans, making them useful for understanding basic biology before attempting human research.
Want to Apply This Research?
- Track daily cravings for high-fat foods on a 1-10 scale and correlate with meal timing, sleep, and stress levels to identify personal triggers. This baseline helps identify patterns that might respond to future treatments.
- Use the app to set reminders for regular meal timing and track which foods genuinely satisfy you versus which ones you crave but don’t enjoy as much. This awareness can help reduce reward-driven eating while this research develops into treatments.
- Create a weekly summary of cravings intensity and eating patterns. Share this data with a healthcare provider to identify whether specific interventions (sleep improvement, stress management, meal structure) reduce cravings naturally while waiting for potential future PTP1B-targeting treatments.
This research describes early-stage laboratory findings in mice and should not be interpreted as medical advice or a basis for dietary changes. PTP1B-targeting treatments do not currently exist for human use. Anyone struggling with food cravings, overeating, or weight management should consult with a healthcare provider or registered dietitian for evidence-based guidance. This article summarizes scientific research but cannot replace professional medical evaluation or treatment recommendations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.